Author Credentials

Marika Shahid, DO

Yong Lee, MD

Gande Li, MD

Chisom Mogbo, DO

Roger Vega, MD

Previously HCA - Coliseum Medical Centers, Currently operating as Piedmont Macon, Georgia

Author ORCID Identifier



Gingival overgrowth, or gingival hyperplasia is the hypertrophy of periodontium caused by local systemic diseases or medications. These medications can be broadly categorized into three main groups including immunosuppressants, anticonvulsants, and calcium channel blockers (CCBs). Amlodipine-induced gingival overgrowth (AIGO) is a less documented phenomenon. This is a unique case of 68-year-old African American woman who developed severe AIGH after taking amlodipine for three years for essential hypertension. The gingival overgrowth happened over a period of two weeks and was so extreme that the patient was unable to approximate her lips or tolerate any oral intake. Labs, images, and biopsies were performed to rule out any other cause of the gingival overgrowth and were negative. AIGO was suspected, and the patient's amlodipine was stopped. At the three-month follow-up, full resolution was noted.

Creative Commons License

Creative Commons Attribution-NonCommercial 4.0 International License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License